4.3 Article

A tyrosine kinase-STAT5-miR21-PDCD4 regulatory axis in chronic and acute myeloid leukemia cells

期刊

ONCOTARGET
卷 8, 期 44, 页码 76174-76188

出版社

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.19192

关键词

CML; STAT5; miR-21; microRNA; leukemia

资金

  1. SIRIC BRIO (Bordeaux Recherche Integree en Oncologie)
  2. Institut National de la Sante et de la Recherche Medicale (INSERM)
  3. University of Bordeaux
  4. Federative Research Structure
  5. Ligue Nationale contre le Cancer (comites Landes and Charentes)

向作者/读者索取更多资源

MicroRNAs (miRNAs) are regulators of several key patho-physiological processes, including cell cycle and apoptosis. Using microarray-based miRNA profiling in K562 cells, a model of chronic myeloid leukemia (CML), we found that the oncoprotein BCR-ABL1 regulates the expression of miR-21, an onco-microRNA, found to be overexpressed in several cancers. This effect relies on the presence of two STAT binding sites on the promoter of miR-21, and on the phosphorylation status of STAT5, a transcription factor activated by the kinase activity of BCR-ABL1. Mir-21 regulates the expression of PDCD4 (programmed cell death protein 4), a tumor suppressor identified through a proteomics approach. The phosphoSTAT5 - miR-21 - PDCD4 pathway was active in CML primary CD34(+) cells, but also in acute myeloid leukemia (AML) models like MV4.11 and MOLM13, where the constitutively active tyrosine kinase FLT3-ITD plays a similar role to BCR-ABL1 in the K562 cell line.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据